Mr. Hunciker's practice is concentrated in complex business and securities litigation. Prior to joining BLB&G, Mr. Hunciker represented clients in a number of class actions and other actions brought under the federal securities laws and the Racketeer Influenced and Corrupt Organizations Act. He has also represented clients in actions brought under intellectual property laws, federal antitrust laws, and the common law governing business relationships.
Mr. Hunciker served as a member of the trial team for the In re WorldCom, Inc. Securities Litigation and, more recently, teams that prosecuted various litigations arising from the financial crisis, including In re Citigroup, Inc. Bond Litigation, In re Wachovia Preferred Securities and Bond/Notes Litigation, In re MBIA Inc. Securities Litigation and, In re Ambac Financial Group, Inc. Securities Litigation. Mr. Hunciker also was a member of the team that prosecuted the In re Schering-Plough Corp./Enhance Securities Litigation and In re Merck & Co., Inc. Vytorin/Zetia Securities Litigation. He presently is a member of the team prosecuting the In re Merck & Co., Inc. Securities Litigation, which arises out of Merck’s alleged failure to disclose adverse facts to investors regarding the risks of Vioxx.